260
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid

, , , , , , & show all
Pages 2225-2234 | Published online: 07 Oct 2011

References

  • DenisJNGreeneAEGuenardDHighly efficient, practical approach to natural taxolJ Am Chem Soc198811059175919
  • MangatalLAdelineMTGuenardDApplication of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron19894541774190
  • GelderblomHVerweijJNooterKCremophor EL: the drawbacks and advantages of vehicle selection for drug formulationEur J Cancer2001371590159811527683
  • ImmordinoMLBrusaPArpiccoSPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release20039141742912932719
  • AlexopoulosAKaramouzisMVStavrinidesHPhase II study of pegylated liposomal doxorubicin (caelyx) and docetaxel as first-line treatment in metastatic breast cancerAnn Oncol20041589189515151945
  • GrossePYBressolleFPinguetFIn vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrinEur J Cancer1998341681749624253
  • MuLFengSSA novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamine E TPGSJ Control Release200386334812490371
  • ChernyshevaYVBabakVGKildeevaNREffect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporationMendeleev Communications2003136568
  • HolzerMVogelVMänteleWPhysico-chemical characterisation of PLGA nanoparticles after freeze-drying and storageEur J Pharm Biopharm20097242843719462479
  • YanFZhangCZhengYThe effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicityNanomedicine2010117017819447200
  • FonsecaCTSimoesSGGasparRGPaclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activityJ Control Release20028327328612363453
  • ManchandaRFernandez-FernandezANagesettiAMcGoronAJPreparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agentsColloids Surf B Biointerfaces20107526026719775872
  • Galindo-RodriguezSAllemannEFessiHPhysicochemical parameters associated with nanoparticle formulation in the salting-out, emulsification-diffusion and nanoprecipitation methodPharm Res2004211428143915359578
  • MainardesRMEvangelistaRCPLGA nanoparticles containing praziquantel: effect of formulation variables on size distributionInt J Pharm200529013714415664139
  • KwonHYLeeJYChoiSWPreparation of PLGA nanoparticles containing estrogen by emulsification-diffusion methodColloids Surf A Physicochem Eng Asp2001182123130
  • FengSSHuangGFEffects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymersJ Control Release200171536911245908
  • MuLFengSSVitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol)J Control Release20028012914411943393
  • ScholesPDCoombesAGIllumLDetection and determination of surface levels of poloxamer and PVA surfactant on and the biodegradable nanospheres using SSIMS and XPSJ Control Release19995926127810332059
  • MusumeciTVenturaCAGiannoneIPLA/PLGA nanoparticles for sustained release of docetaxelInt J Pharm200632517217916887303
  • CoatesJInterpretation of infrared spectra, a practical approachMeyersRQEncyclopedia of Analytical ChemistryChichester, UKJohn Wiley & Sons Ltd2000
  • AsteteCESabliovCMSynthesis and characterization of PLGA nanoparticlesJ Biomater Sci Polym Ed200617324728916689015